Claudins Overexpression in Ovarian Cancer: Potential Targets for Clostridium Perfringens Enterotoxin (CPE) Based Diagnosis and Therapy

被引:47
作者
English, Diana P. [1 ]
Santin, Alessandro D. [1 ]
机构
[1] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA
关键词
tight junction; claudin; clostridium perfringens enterotoxin; ovarian cancer; immuno-therapy; TIGHT JUNCTION PROTEINS; DIFFERENTIAL GENE-EXPRESSION; ENDOTHELIAL GROWTH-FACTOR; CANDIDATE MOLECULAR MARKERS; C-TERMINAL FRAGMENT; BARRIER FUNCTION; SERIAL ANALYSIS; DOWN-REGULATION; CELL-ADHESION; RECEPTORS CLAUDIN-3;
D O I
10.3390/ijms140510412
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Claudins are a family of tight junction proteins regulating paracellular permeability and cell polarity with different patterns of expression in benign and malignant human tissues. There are approximately 27 members of the claudin family identified to date with varying cell and tissue-specific expression. Claudins-3, -4 and -7 represent the most highly differentially expressed claudins in ovarian cancer. While their exact role in ovarian tumors is still being elucidated, these proteins are thought to be critical for ovarian cancer cell invasion/dissemination and resistance to chemotherapy. Claudin-3 and claudin-4 are the natural receptors for the Clostridium perfringens enterotoxin (CPE), a potent cytolytic toxin. These surface proteins may therefore represent attractive targets for the detection and treatment of chemotherapy-resistant ovarian cancer and other aggressive solid tumors overexpressing claudin-3 and -4 using CPE-based theranostic agents.
引用
收藏
页码:10412 / 10437
页数:26
相关论文
共 153 条
[1]   Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity [J].
Agarwal, R ;
D'Souza, T ;
Morin, P .
CANCER RESEARCH, 2005, 65 (16) :7378-7385
[2]   Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells [J].
Al Moustafa, AE ;
Alaoui-Jamali, MA ;
Batist, G ;
Hernandez-Perez, M ;
Serruya, C ;
Alpert, L ;
Black, MJ ;
Sladek, R ;
Foulkes, WD .
ONCOGENE, 2002, 21 (17) :2634-2640
[3]   Intraperitoneal therapy for stage III ovarian cancer: A therapy whose time has come! [J].
Alberts, DS ;
Markman, M ;
Armstrong, D ;
Rothenberg, ML ;
Muggia, F ;
Howell, SB .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (19) :3944-3946
[4]   Genetic targeting of the endoderm with Claudin-6CreER [J].
Anderson, William J. ;
Zhou, Qiao ;
Alcalde, Victor ;
Kaneko, Osamu F. ;
Blank, Leah J. ;
Sherwood, Richard I. ;
Guseh, J. Sawalla ;
Rajagopal, Jayaraj ;
Melton, Douglas A. .
DEVELOPMENTAL DYNAMICS, 2008, 237 (02) :504-512
[5]   The molecular signature of endometriosis-associated endometrioid ovarian cancer differs significantly from endometriosis-independent endometrioid ovarian cancer [J].
Banz, Constanze ;
Ungethuem, Ute ;
Kuban, Ralf-Juergen ;
Diedrich, Klaus ;
Lengyel, Ernst ;
Hornung, Daniela .
FERTILITY AND STERILITY, 2010, 94 (04) :1212-1217
[6]  
Bellone S., 2013, BR J CANC UNPUB
[7]   Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: Identification of novel molecular biomarkers for early diagnosis and therapy [J].
Bignotti, Eliana ;
Tassi, Renata A. ;
Calza, Stefano ;
Ravaggi, Antonella ;
Romani, Chiara ;
Rossi, Elisa ;
Falchetti, Marcella ;
Odicino, Franco E. ;
Pecorelli, Sergio ;
Santin, Alessandro D. .
GYNECOLOGIC ONCOLOGY, 2006, 103 (02) :405-416
[8]   Claudin 6 Is a Positive Marker for Atypical Teratoid/Rhabdoid Tumors [J].
Birks, Diane K. ;
Kleinschmidt-DeMasters, Bette K. ;
Donson, Andrew M. ;
Barton, Valerie N. ;
McNatt, Sean A. ;
Foreman, Nicholas K. ;
Handler, Michael H. .
BRAIN PATHOLOGY, 2010, 20 (01) :140-150
[9]   Claudin 4 Is Differentially Expressed between Ovarian Cancer Subtypes and Plays a Role in Spheroid Formation [J].
Boylan, Kristin L. M. ;
Misemer, Benjamin ;
DeRycke, Melissa S. ;
Andersen, John D. ;
Harrington, Katherine M. ;
Kalloger, Steve E. ;
Gilks, C. Blake ;
Pambuccian, Stefan E. ;
Skubitz, Amy P. N. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2011, 12 (02) :1334-1358
[10]   Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis [J].
Bristow, RE ;
Tomacruz, RS ;
Armstrong, DK ;
Trimble, EL ;
Montz, FJ .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) :1248-1259